Deficiency of pulmonary Vα24 Vβ11 natural killer T cells in corticosteroid-naïve sarcoidosis patients

Respiratory Medicine

Volumn 104, Issue 4, 2010, Pages 571-577

  Korosec, Peter ^a   Rijavec, Matija ^a   Silar, Mira ^a   Kern, Izidor ^a   Kosnik, Mitja ^a   Osolnik, Katarina ^a  

^a UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; VALPHA24 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNODEFICIENCY; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOREGULATION; LUNG LAVAGE; LYMPHOCYTOSIS; MALE; NATURAL KILLER T CELL; PRIORITY JOURNAL; SARCOIDOSIS; CASE CONTROL STUDY; CD4 CD8 RATIO; CYTOLOGY; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CD4-CD8 RATIO; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL; SARCOIDOSIS, PULMONARY;

EID: 77549087968     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.11.008     Document Type: Article

References (37)

1. Agostini C., Meneghin A., and Semenzato G. T-lymphocytes and cytokines in sarcoidosis. Curr Opin Pulm Med. 8 5 (2002 Sep) 435-440
2. Ho L.P., Urban B.C., Thickett D.R., Davies R.J., and McMichael A.J. Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis. Lancet 365 9464 (2005 Mar 19-25) 1062-1072
3. Norris S., Doherty D.G., Collins C., McEntee G., Traynor O., Hegarty J.E., and O'Farrelly C. Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells. Hum Immunol 60 1 (1999 Jan) 20-31
4. Kronenberg M., and Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2 8 (2002 Aug) 557-568
5. Matsuda J.L., Gapin L., Fazilleau N., Warren K., Naidenko O.V., and Kronenberg M. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size. Proc Natl Acad Sci U S A 98 22 (2001 Oct 23) 12636-12641
6. Wajchman H.J., Pierce C.W., Varma V.A., Issa M.M., Petros J., and Dombrowski K.E. Ex vivo expansion of CD8+ CD56+ and CD8+ CD56-natural killer T cells specific for MUC1 mucin. Cancer Res 64 3 (2004 Feb 1) 1171-1180
7. Korosec P., Osolnik K., Kern I., Silar M., Mohorcic K., and Kosnik M. Expansion of pulmonary CD8+ CD56+ natural killer T-cells in hypersensitivity pneumonitis. Chest 132 4 (2007 Oct) 1291-1297
8. Kadowaki N., Antonenko S., Ho S., Rissoan M.C., Soumelis V., Porcelli S.A., Lanier L.L., and Liu Y.J. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med 193 (2001) 1221-1226
9. Brigl M., Bry L., Kent S.C., Gumperz J.E., and Brenner M.B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 4 (2003) 1230-1237
10. Crowe N.Y., Coquet J.M., Berzins S.P., Kyparissoudis K., Keating R., Pellicci D.G., Hayakawa Y., Godfrey D.I., and Smyth M.J. Differential antitumor immunity mediated by NKT cell subsets in vivo. J Exp Med 202 (2005) 1279-1288
11. Shimizu K., Goto A., Fukui M., Taniguchi M., and Fujii S. Tumor cells loaded with _-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice. J Immunol 178 (2007) 2853-2861
12. Sonoda K.H., Exley M., Snapper S., Balk S.P., and Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med 190 (1999) 1215-1226
13. Sharif S., Arreaza G.A., Zucker P., Mi Q.S., Sondhi J., Naidenko O.V., Kronenberg M., Koezuka Y., Delovitch T.L., Gombert J.M., et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat Med 7 (2001) 1057-1062
14. Hong S., Wilson M.T., Serizawa I., Wu L., Singh N., Naidenko O.V., Miura T., Haba T., Scherer D.C., Wei J., et al. The natural killer T-cell ligand-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 7 (2001) 1052-1056
15. Miyamoto K., Miyake S., and Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413 (2001) 531-534
16. Jahng A.W., Maricic I., Pedersen B., Burdin N., Naidenko O., Kronenberg M., Koezuka Y., and Kumar V. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med 194 (2001) 1789-1799
17. Kaieda S., Tomi C., Oki S., Yamamura T., and Miyake S. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody induced arthritis. Arthritis Rheum 56 (2007) 1836-1845
18. ATS/ERS/WASOG Committee. Statement on sarcoidosis. Am J Respir Crit Care Med 160 (1999) 736-755
19. Scadding J.G. Prognosis of intrathoracic sarcoidosis in England. Br Med J 4 (1961) 1165-1172
20. Akbari O., Faul J.L., Hoyte E.G., Berry G.J., Wahlstrom J., Kronenberg M., DeKruyff R.H., and Umetsu D.T. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med. 354 11 (2006 Mar 16) 1117-1129
21. Vijayanand P., Seumois G., Pickard C., Powell R.M., Angco G., Sammut D., Gadola S.D., Friedmann P.S., and Djukanovic R. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med. 356 14 (2007 Apr 5) 1410-1422
22. Thomas S.Y., Lilly C.M., and Luster A.D. Invariant natural killer T cells in bronchial asthma. N Engl J Med. 354 24 (2006 Jun 15) 2613-2616
23. Mempel M., Flageul B., Suarez F., Ronet C., Dubertret L., Kourilsky P., Gachelin G., and Musette P. Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Valpha24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Valpha repertoire. Am J Pathol 157 2 (2000 Aug) 509-523
24. Kobayashi S., Kaneko Y., Seino K., Yamada Y., Motohashi S., Koike J., Sugaya K., Kuriyama T., Asano S., Tsuda T., Wakao H., Harada M., Kojo S., Nakayama T., and Taniguchi M. Impaired IFN-gamma production of Valpha24 NKT cells in non-remitting sarcoidosis. Int Immunol 16 2 (2004 Feb) 215-222
25. Roberts S.D., Kohli L.L., Wood K.L., Wilkes D.S., and Knox K.S. CD4+ CD28-T cells are expanded in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22 1 (2005 Mar) 13-19
26. Grunewald J., Wahlström J., Berlin M., Wigzell H., Eklund A., and Olerup O. Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax 57 4 (2002 Apr) 348-352
27. Wilson S.B., Kent S.C., Patton K.T., Orban T., Jackson R.A., Exley M., Porcelli S., Schatz D.A., Atkinson M.A., Balk S.P., Strominger J.L., and Hafler D.A. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391 6663 (1998 Jan 8) 177-181
28. Baughman R.P., and Lower E.E. Treatment of sarcoidosis with corticosteroids: who is going to relapse and why?. Sarcoidosis Vasc Diffuse Lung Dis. 15 1 (1998 Mar) 19-20
29. Katchar K., Soderstrom K., Wahlstrom J., Eklund A., and Grunewald J. Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients. Eur Respir J. 26 1 (2005 Jul) 77-85
30. Papakosta D., Kyriazis G., Gioulekas D., Kontakiotis T., Polyzoni T., Bouros D., and Patakas D. Variations in alveolar cell populations, lymphocyte subsets and NK-cells in different stages of active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 22 1 (2005 Mar) 21-26
31. Akbari O., Stock P., Meyer E., Kronenberg M., Sidobre S., Nakayama T., Taniguchi M., Grusby M.J., DeKruyff R.H., and Umetsu D.T. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med. 9 5 (2003 May) 582-588
32. Mutalithas K., Croudace J., Guillen C., Siddiqui S., Thickett D., Wardlaw A., Lammas D., and Brightling C.J. Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma. J Allergy Clin Immunol 119 5 (2007 May) 1274-1276
33. Matangkasombut P., Marigowda G., Ervine A., Idris L., Pichavant M., Kim H.Y., Yasumi T., Wilson S.B., DeKruyff R.H., Faul J.L., Israel E., Akbari O., and Umetsu D.T. Natural killer T cells in the lungs of patients with asthma. J Allergy Clin Immunol 123 5 (2009 May) 1181-1185
34. Baev D.V., Caielli S., Ronchi F., Coccia M., Facciotti F., Nichols K.E., and Falcone M. Impaired SLAM-SLAM homotypic interaction between invariant NKT cells and dendritic cells affects differentiation of IL-4/IL-10-secreting NKT2 cells in nonobese diabetic mice. J Immunol. 181 2 (2008 Jul 15) 869-877
35. Jordan M.A., Fletcher J.M., Pellicci D., and Baxter A.G. Slamf1, the NKT cell control gene Nkt1. J Immunol 178 (2007) 1618-1627
36. Cantorna M.T., Yu S., and Bruce D. The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci U S A 105 13 (2008 Apr 1) 5207-5212
37. Niimi T., Tomita H., Sato S., Kawaguchi H., Akita K., Maeda H., Sugiura Y., and Ueda R. Vitamin D receptor gene polymorphism in patients with sarcoidosis. Am J Respir Crit Care Med 160 4 (1999 Oct) 1107-1109